| Data | Hora | Fonte | Título | Código | Companhia |
| 21/08/2019 | 13:45 | InvestorsHub NewsWire | FSD Pharma Launches Online Ordering System for Medicinal Cannabis Fulfillment | CSE:HUGE | FSD Pharma Inc |
| 06/05/2019 | 08:00 | InvestorsHub NewsWire | FSD Pharma Reports 2018 Year-End Results | CSE:HUGE | FSD Pharma Inc |
| 24/04/2019 | 05:25 | InvestorsHub Cannabis NewsWire | FSD Pharma Announces Share Exchange Transaction with Aura Health | CSE:HUGE | FSD Pharma Inc |
| 23/04/2019 | 05:56 | InvestorsHub NewsWire | FSD Pharma to Acquire Prismic Pharmaceuticals | CSE:HUGE | FSD Pharma Inc |
| 22/04/2019 | 09:00 | InvestorsHub NewsWire | FSD Pharma Receives Cannabis Sales License from Health Canada | CSE:HUGE | FSD Pharma Inc |
| 04/04/2019 | 08:30 | InvestorsHub NewsWire | FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of theScientific Advisory Board | CSE:HUGE | FSD Pharma Inc |
| 28/03/2019 | 08:30 | InvestorsHub Cannabis NewsWire | FSD PHARMA TO ESTABLISH PRESENCE IN CANADA'S INSURANCE REGIMES | CSE:HUGE | FSD Pharma Inc |
| 28/02/2019 | 09:30 | InvestorsHub Cannabis NewsWire | FSD Pharma Enters into Five Year Supply & Loan Agreement w/ Canntab Therapeutics & World Class Extractions on Organic Hemp Deal | CSE:HUGE | FSD Pharma Inc |
| 19/02/2019 | 06:12 | InvestorsHub Cannabis NewsWire | FSD PHARMA RECEIVES STANDARD PROCESSING LICENSE | CSE:HUGE | FSD Pharma Inc |
| 14/02/2019 | 10:35 | InvestorsHub Cannabis NewsWire | FSD Pharma Provides Update on Operations, Strategy and Leadership | CSE:HUGE | FSD Pharma Inc |
| 12/02/2019 | 10:47 | InvestorsHub Cannabis NewsWire | FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal | CSE:HUGE | FSD Pharma Inc |
| 07/02/2019 | 08:00 | InvestorsHub Cannabis NewsWire | FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical ... | CSE:HUGE | FSD Pharma Inc |
| 05/02/2019 | 09:26 | InvestorsHub Cannabis NewsWire | FSD PHARMA ANNOUNCES SIGNING OF LOI WITH SOLARVEST TO DEVELOP AND TEST PHARMA-GRADE CANNABINOIDS OUT OF ALGAE | CSE:HUGE | FSD Pharma Inc |
| 08/01/2019 | 13:00 | InvestorsHub Cannabis NewsWire | FSD Pharma Completes Harvest and Passes Analytical Testing of Second Lot | CSE:HUGE | FSD Pharma Inc |
| 20/12/2018 | 12:36 | InvestorsHub Cannabis NewsWire | FSD Pharma Announces Strategic Investment in Huge Shops | CSE:HUGE | FSD Pharma Inc |
| 12/12/2018 | 12:00 | InvestorsHub Cannabis NewsWire | FSD Pharma Featured in CannaInvestor Magazine December Issue | CSE:HUGE | FSD Pharma Inc |
| 06/12/2018 | 12:40 | InvestorsHub Cannabis NewsWire | FSD Pharma Announces Collaboration and License Agreement with World Class Extractions | CSE:HUGE | FSD Pharma Inc |
| 03/12/2018 | 10:30 | InvestorsHub Cannabis NewsWire | FSD Pharma Hits Over 4 Billion Shares Traded in First 6 Months | CSE:HUGE | FSD Pharma Inc |
| 30/11/2018 | 10:30 | InvestorsHub Cannabis NewsWire | FSD Pharma Reports Positive Q3 Results | CSE:HUGE | FSD Pharma Inc |
| 29/11/2018 | 10:30 | InvestorsHub Cannabis NewsWire | FSD Pharma and SciCann Therapeutics to Present at the iCDP Summit in Boston | CSE:HUGE | FSD Pharma Inc |
| 28/11/2018 | 10:30 | InvestorsHub NewsWire | FSD Pharma Facility Valued at $105,000,000 with 3,000,000 FT. Expansion Assessed at $420,000,000 | CSE:HUGE | FSD Pharma Inc |
| 26/11/2018 | 10:30 | InvestorsHub Cannabis NewsWire | FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer | CSE:HUGE | FSD Pharma Inc |
| 14/11/2018 | 05:00 | InvestorsHub Cannabis NewsWire | FSD PHARMA ADDS DAVID URBAN TO BOARD OF DIRECTORS | CSE:HUGE | FSD Pharma Inc |
| 13/11/2018 | 10:30 | InvestorsHub Cannabis NewsWire | FSD PHARMA RECEIVES LICENSE TO SELL TO OTHER LICENSED PRODUCERS AND EXPANDS GROWTH PRODUCTION FOOTPRINT | CSE:HUGE | FSD Pharma Inc |
| 06/11/2018 | 10:30 | InvestorsHub Cannabis NewsWire | FSD Pharma Announces Positive ISA Report For "Steady Stomach" CBD Combination | CSE:HUGE | FSD Pharma Inc |
| 30/10/2018 | 09:24 | InvestorsHub Cannabis NewsWire | FSD Pharma Co-Chairman, Anthony Durkacz, Featured in Bloomberg Article | CSE:HUGE | FSD Pharma Inc |
| 29/10/2018 | 08:30 | InvestorsHub NewsWire | FSD Pharma Appoints Dr. Raza Bokhari as Interim CEO & Co-chairman, Anthony Durkacz as Co-Chairman & Zeeshan Saeed as President | CSE:HUGE | FSD Pharma Inc |
| 25/10/2018 | 08:30 | InvestorsHub NewsWire | FSD Pharma Announces Issuance of Cannabis License Under Excise Act | CSE:HUGE | FSD Pharma Inc |
| 23/10/2018 | 13:22 | InvestorsHub Cannabis NewsWire | FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a NASDAQ Traded Pharmaceutical Company | CSE:HUGE | FSD Pharma Inc |
| 17/10/2018 | 10:54 | InvestorsHub NewsWire | FSD Pharma Featured on CTV Toronto | CSE:HUGE | FSD Pharma Inc |